null
null
OncologyStat
®
One Source, Many Resources.
®
By Elsevier
MULTIPLE MYELOMA
Refine Results:
All Categories
Epidemiology and Etiology (116)
Prevention and Screening (37)
Diagnosis and Staging (111)
Treatment (345)
Supportive Oncology (46)
CME
Clinical Cliffhangers: Case-Based Challenges for the Risk Assessment and Prophylaxis of Tumor Lysis Syndrome
An interactive CME program provided by Med-IQ
News
Lenalidomide Maintenance Stalls Myeloma in Trio of Clinical Trials
Elsevier Global Medical News, 2012 May 9, JS MacNeil
FDA Warning: Second Cancers Can Follow Lenalidomide in Myeloma
Elsevier Global Medical News, 2012 May 7, E Mechcatie
Profile Predicts Longer Survival in Multiple Myeloma
Elsevier Global Medical News, 2012 Apr 30, MA Moon
Onyx’s Kyprolis Heads to ODAC With Open-label Trial; Will Desperation Outweigh Doubts?
The Pink Sheet Daily, 2012 Apr 26, M Berman-Gorvine
Study: Myeloma Survival Gains, but QOL Slides
Elsevier Global Medical News, 2012 Mar 16, BB Freed
More News ›
Journal Scans: Research
Lenalidomide, Cyclophosphamide and Dexamethasone (CRd) for Light Chain Amyloidosis: Long Term Results From a Phase 2 Trial
Blood, 2012 Apr 13, SK Kumar, et al
Cancer Incidence in Patients With Polyglutamine Diseases
Lancet Oncol, 2012 Apr 12, J Ji, et al
The Impact of Platelet Transfusion Characteristics on Post-Transfusion Platelet Increments and Clinical Bleeding in Patients With Hypo-Proliferative Thrombocytopenia
Blood, 2012 Apr 10, DJ Triulzi, et al
The Activity of Pomalidomide in Patients with Immunoglobulin Light Chain Amyloidosis
Blood, 2012 Apr 4, A Dispenzieri, et al
Should All Eligible Patients With Multiple Myeloma Receive Autologous Stem-Cell Transplant as Part of Initial Treatment?
Leuk Res, 2012 Mar 17, Philippe Moreau, et al
More Journal Scans: Research ›
Journal Scans: Review
Bisphosphonate-Related Osteonecrosis of the Jaws – A Review
Oral Oncol, 2012 Apr 23, S Kuhl, et al
Systemic Therapy for Bone Metastases
Cancer Control, 2012 Apr 19, LS Loftus, et al
Role of Histone Deacetylase Inhibitors in the Treatment of Lymphomas and Multiple Myeloma
Hematol Oncol Clin North Am, 2012 Mar 27, J Zain
Why Does My Patient Have Lymphadenopathy or Splenomegaly?
Hematol Oncol Clin North Am, 2012 Mar 14, G Motyckova, et al
Radiopharmaceuticals: When and How to Use Them to Treat Metastatic Bone Pain
J Support Oncol, 2011 Nov 1, FM Paes, et al
More Journal Scans: Review ›
Expert Opinion
Seminal Articles—Growth Factor Support
2012 Mar 26, David Henry, et al
Dr. David Henry: It Just Keeps Getting Better and Better in Myeloma
Interview by L Scott Zoeller, 2012 Jan 25, David Henry, et al
Is There a Future for Auto-Allo HSCT in Multiple Myeloma?
Lancet Oncol, 2011 Sept 30, A Dispenzieri
Zoledronic Acid for All Patients With Newly Diagnosed Multiple Myeloma?
Lancet Oncol, 2011 Aug 1, E Terpos, et al
Subcutaneous Bortezomib: A Step Towards Optimised Drug Use
Lancet Oncol, 2011 Apr 19, M-V Mateos
More Expert Opinion ›
Chemotherapy Regimens
VAD (vincristine, doxorubicin [Adriamycin], dexamethasone) (Multiple myeloma)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Thalidomide, dexamethasone (Multiple myeloma)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Thalidomide (Multiple myeloma)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Bortezomib (Multiple myeloma)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Melphalan, prednisone, thalidomide (MPT) (Multiple myeloma)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
More Chemotherapy Regimens ›
Conference Coverage
2011 ASH Annual Meeting and Exposition
Dec 10-13 2011 San Diego, et al
16th Congress of EHA
June 9-12 2011 London
Videos
Physicians' Roundtable: Setting Expectations for Cancer Patients
Elsevier Global Medical News, 2012 Apr 2
Multiple Myeloma: New Therapies and Changing Cytogenetics
Elsevier Global Medical News, 2012 Jan 3
Modified VISTA in Myeloma
Elsevier Global Medical News, 2009 Dec 7, JS MacNeil
Summary of Key Points
Multiple Myeloma and Related Disorders
Abeloff's Clinical Oncology, 4th ed. 2008
Comment
Print page
Share page
RSS feeds
Updated Key Points: Multiple Myeloma
Summary information about multiple myeloma cancer has been completely revised with updated information from Abeloff's Clinical Oncology, 4th ed.
Read more ›
ASCO
Read through news articles of studies from this year's conference.
Read more ›
Categories
News
Journal Scans
Expert Opinion
Drugs and Regimens
Conferences
CME
Videos
Supportive Care
Skeletal-Related Events
Complications, GI and Oral
Hematologic Support
Infectious Complications
Neurologic Complications
Pain
Vascular Complications
Cancer Type
Bladder
Bone
Breast
Breast (ER-Positive)
CNS/Brain
Colon and Rectum
Endocrine System
Esophagus
GYN (Non-Ovary)
GYN (Ovary)
Head and Neck
Hodgkin's Lymphoma
Kidney (Renal Cell)
Leukemia
Liver and Bile Duct
Lung
Multiple Myeloma
Myelodysplastic Syndrome
Myeloproliferative Diseases
Non-Hodgkin's Lymphoma
Pancreas
Pediatric Cancers
Prostate
Rare Cancers
Skin
Soft-Tissue Sarcoma
Stomach
Testicle
MultipleMyeloma/
anonymous
none
none
none
n
Advanced Search
Email Address
Password
Remember Me
Forgot your password?
Not a member?
Free registration
Elsevier
Home
Site Map
Cancer Types
About OncologySTAT
Privacy Policy
Terms of Use
Contact Us
Advertise
Copyright © 2012
Elsevier Inc.
All rights reserved.